Reteplase(Angde Biotech Pharmaceutical)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameReteplase(Angde Biotech Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > EnzymeBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsStrokePulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAngde Biotech Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAngde Biotech Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStrokePulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A